{"id":"https://openalex.org/W4397012962","doi":"https://doi.org/10.1158/1557-3265.bladder24-b012","title":"Abstract B012: BET inhibition sensitizes preclinical models of bladder cancer to DDR inhibitors","display_name":"Abstract B012: BET inhibition sensitizes preclinical models of bladder cancer to DDR inhibitors","publication_year":2024,"publication_date":"2024-05-17","ids":{"openalex":"https://openalex.org/W4397012962","doi":"https://doi.org/10.1158/1557-3265.bladder24-b012"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.bladder24-b012","doi":"https://doi.org/10.1158/1557-3265.bladder24-b012","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.bladder24-b012","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027637322","display_name":"Ryan M. Kemper","orcid":"https://orcid.org/0000-0002-5468-7827","observed_orcids":["https://orcid.org/0000-0002-5468-7827"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan M. Kemper","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028813559","display_name":"Bhavika C. Chirumamilla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhavika C. Chirumamilla","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088441683","display_name":"Dennis A. Simpson","orcid":"https://orcid.org/0000-0001-5332-8243","observed_orcids":["https://orcid.org/0000-0001-5332-8243"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis A. Simpson","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022798031","display_name":"Manfred Meng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manfred Meng","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112864074","display_name":"Gaorav P. Gupta","orcid":"https://orcid.org/0000-0001-9177-552X","observed_orcids":["https://orcid.org/0000-0001-9177-552X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaorav P. Gupta","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079183709","display_name":"Daniel James Crona","orcid":"https://orcid.org/0000-0003-3742-8863","observed_orcids":["https://orcid.org/0000-0003-3742-8863"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Crona","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"10_Supplement","first_page":"B012","last_page":"B012"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.41359999775886536,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.39160001277923584,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.13379999995231628,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6840000152587891},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8619999885559082},{"id":"https://openalex.org/keywords/polymerase-theta","display_name":"polymerase theta","score":0.7450000047683716},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.8510000109672546},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.7850000262260437},{"id":"https://openalex.org/keywords/rbbp8","display_name":"RBBP8","score":0.7789999842643738},{"id":"https://openalex.org/keywords/dna-polymerase-theta","display_name":"DNA polymerase theta","score":0.7080000042915344},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8330000042915344},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5429999828338623},{"id":"https://openalex.org/keywords/non-homologous-end-joining","display_name":"non-homologous end joining","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6179531216621399},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6126240491867065},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6029897928237915},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4224485754966736},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41620194911956787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3072640299797058}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.bladder24-b012","doi":"https://doi.org/10.1158/1557-3265.bladder24-b012","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.bladder24-b012","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311194923","https://openalex.org/W4401455145","https://openalex.org/W4382010766","https://openalex.org/W4200475788","https://openalex.org/W4393096467","https://openalex.org/W4393071193","https://openalex.org/W2940958940","https://openalex.org/W2893385575","https://openalex.org/W4362593130","https://openalex.org/W4282925223"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Bladder":[2,499],"cancer":[3,486],"(BC)":[4],"remains":[5],"a":[6,159,162,167,429],"common":[7],"and":[8,14,27,43,59,73,125,128,142,153,166,180,212,267,279,306,313,336,349,366,373,386,407,412,419,426,434],"deadly":[9],"disease,":[10],"with":[11,132,148,158,176,198,203,230,244,342,356,378],"83,190":[12],"cases":[13],"32,350":[15],"deaths":[16],"projected":[17],"in":[18,21,34,111,242,303,333,363,455],"the":[19,195,225,235,246,359,494,502],"U.S.":[20],"2024.":[22],"We":[23],"previously":[24],"showed":[25,46],"bromodomain":[26],"extra-terminal":[28],"protein":[29],"inhibitors":[30,489],"(BETi)":[31],"are":[32,81,105],"potent":[33],"multiple":[35],"preclinical":[36,456,482],"models":[37,457,483],"of":[38,51,234,446,458,484,493],"BC.":[39,459],"Our":[40],"bulk":[41],"RNA-seq":[42],"RT-qPCR":[44,283],"data":[45,94,442],"BETi":[47,133,236],"significantly":[48,300,322,392],"reduces":[49],"expression":[50,217,288,329,395,416,448],"homologous":[52],"recombination":[53],"(HR)":[54],"genes,":[55],"such":[56],"as":[57],"RAD51":[58,254],"RBBP8,":[60],"which":[61],"could":[62],"activate":[63],"alternative":[64],"DNA":[65,79],"repair":[66],"pathways":[67],"including":[68],"non-homologous":[69],"end":[70,75],"joining":[71,76],"(NHEJ)":[72],"theta-mediated":[74],"(TMEJ).":[77],"Specifically,":[78],"breaks":[80],"repaired":[82],"through":[83],"TMEJ":[84,124,302],"by":[85,186,222,451],"polymerase":[86],"theta":[87],"(Pol\u03b8)":[88],"utilizing":[89],"microhomology":[90],"templates.":[91],"Recently":[92],"published":[93],"revealed":[95],"Pol\u03b8":[96],"inhibition":[97,480],"is":[98],"synthetically":[99],"lethal":[100],"when":[101],"other":[102],"DDR":[103,181,488],"genes":[104],"concomitantly":[106],"lost":[107],"or":[108,241,253,325],"inhibited.":[109],"Thus,":[110],"this":[112],"study,":[113],"we":[114],"sought":[115],"to":[116,129,214,286,290,487],"elucidate":[117],"whether":[118],"BETi-induced":[119],"HR":[120,170,324],"gene":[121,216],"repression":[122],"impacts":[123],"POLQ":[126,291,327,394,415,447],"expression,":[127],"identify":[130],"combinations":[131],"that":[134],"best":[135],"leverage":[136],"Pol\u03b8-mediated":[137],"synthetic":[138],"lethality.":[139],"Methods:":[140],"5637":[141,305,335,365,406],"J82":[143,307,337,367,389,408],"BC":[144,190,308,338,368],"cells":[145,173,191,209,227,309,339,369,409],"were":[146,174,192,210,228],"pretreated":[147],"birabresib":[149,177,204,237,299,343,376,391,411,425],"for":[150,178],"24":[151],"h":[152],"then":[154],"transfected":[155],"via":[156],"electroporation":[157],"Cas9":[160],"ribonucleoprotein,":[161],"gRNA":[163],"targeting":[164],"LBR2":[165],"996":[168],"bp":[169],"donor.":[171],"Transfected":[172],"treated":[175,229],"24H,":[179],"pathway":[182],"function":[183],"was":[184,220,284,330,358,380],"assessed":[185,221],"digital":[187],"droplet":[188],"PCR.":[189],"synchronized":[193,334],"at":[194],"G1/S":[196],"transition":[197],"2":[199],"mM":[200],"thymidine":[201],"incubated":[202],"alone.":[205],"After":[206,260,296],"48":[207,297],"h,":[208,262,298],"harvested,":[211],"changes":[213,289],"target":[215],"(i.e.,":[218],"POLQ)":[219],"RT-qPCR.":[223],"Next,":[224],"same":[226],"8":[231],"ascending":[232],"doses":[233],"(0.1\u2013100":[238],"\u03bcM)":[239],"alone":[240,344],"combination":[243,271,293,362],"either":[245],"PARP":[247],"inhibitor":[248,251,255],"olaparib,":[249],"CtIP":[250],"triapene,":[252],"RI-1":[256],"(10":[257],"nM\u2013200":[258],"\u03bcM).":[259],"72-96":[261],"CellTiter-Glo\u2122":[263],"measured":[264],"cell":[265],"viability,":[266],"Compusyn":[268],"v1":[269],"calculated":[270],"index":[272],"(CI)":[273],"scores":[274],"where":[275],"<1.0":[276],"indicated":[277,281],"synergism":[278],">1.0":[280],"antagonism.":[282],"conducted":[285],"evaluate":[287],"after":[292,340],"treatment.":[294],"Results:":[295],"reduced":[301,332,393],"both":[304,317,364,405],"(49%":[310],"reduction,":[311,315,346,351,397],"P=0.008":[312],"41%":[314],"P=0.004":[316],"n=3),":[318,399],"but":[319,375,400],"did":[320,402],"not":[321],"impact":[323],"NHEJ.":[326],"mRNA":[328],"most":[331,360],"treatment":[341,454],"(46%":[345,432],"P=0.006,":[347],"n=3,":[348],"38%":[350],"P=0.001,":[352],"n=3).":[353,423,438],"Birabresib":[354],"combined":[355,377,410,452],"olaparib":[357,401,413],"synergistic":[361,382],"(CI":[370,383],"=":[371,384],"0.83":[372],"0.29),":[374],"triapene":[379,427],"also":[381],"0.91":[385],"0.90).":[387],"In":[388,404],"cells,":[390],"(27%":[396],"P=0.008,":[398],"not.":[403],"increased":[414],"(41%":[417],"increase":[418,433],"5%":[420],"increase,":[421,436],"ns,":[422,437],"Combined":[424],"displayed":[428],"similar":[430],"trend":[431],"17%":[435],"Conclusions:":[439],"These":[440],"preliminary":[441],"support":[443],"further":[444],"exploration":[445],"increases":[449],"caused":[450],"BETi+DDRi":[453],"Citation":[460],"Format:":[461],"Ryan":[462],"M.":[463],"Kemper,":[464],"Bhavika":[465],"C.":[466],"Chirumamilla,":[467],"Dennis":[468],"A.":[469],"Simpson,":[470],"Manfred":[471],"Meng,":[472],"Gaorav":[473],"P.":[474],"Gupta,":[475],"Daniel":[476],"J.":[477],"Crona.":[478],"BET":[479],"sensitizes":[481],"bladder":[485],"[abstract].":[490],"In:":[491],"Proceedings":[492],"AACR":[495],"Special":[496],"Conference":[497],"on":[498],"Cancer:":[500],"Transforming":[501],"Field;":[503],"2024":[504],"May":[505],"17-20;":[506],"Charlotte,":[507],"NC.":[508],"Philadelphia":[509],"(PA):":[510],"AACR;":[511],"Clin":[512],"Cancer":[513],"Res":[514],"2024;30(10_Suppl):Abstract":[515],"nr":[516],"B012.":[517]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-18T00:00:00"}